000 01358 a2200385 4500
005 20250512001026.0
264 0 _c19860410
008 198604s 0 0 eng d
022 _a0012-3692
024 7 _a10.1378/chest.89.3_supplement.123s
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKennedy, J I
245 0 0 _aReduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent.
_h[electronic resource]
260 _bChest
_cMar 1986
300 _a123S-125S p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBleomycin
_xtoxicity
650 0 4 _aChelating Agents
_xpharmacology
650 0 4 _aCricetinae
650 0 4 _aDeferoxamine
_xpharmacology
650 0 4 _aHydroxyproline
_xanalysis
650 0 4 _aIron
_xphysiology
650 0 4 _aLung
_xanalysis
650 0 4 _aMale
650 0 4 _aMesocricetus
650 0 4 _aOxygen
_xmetabolism
650 0 4 _aPulmonary Fibrosis
_xchemically induced
650 0 4 _aRats
700 1 _aChandler, D B
700 1 _aJackson, R M
700 1 _aFulmer, J D
773 0 _tChest
_gvol. 89
_gno. 3 Suppl
_gp. 123S-125S
856 4 0 _uhttps://doi.org/10.1378/chest.89.3_supplement.123s
_zAvailable from publisher's website
999 _c2425102
_d2425102